Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partnering Agreement with INSOMNIS Media Limited

28 Oct 2015 07:00

RNS Number : 6403D
Phorm Corporation Limited
28 October 2015
 

28 October 2015

 

Phorm Corporation Limited

("Phorm" or the "Company")

 

Partnering Agreement with INSOMNIS Media Limited

Channel sales partnership entered into with INSOMNIS to expand its technology footprint and improve global advertising campaign performance

Phorm (AIM:PHRM), a leading advertising-technology company and first party data platform provider, is pleased to announce that, further to its interim results released on 30 September 2015, it has formally entered into a channel sales partnership with INSOMNIS Media Limited ("INSOMNIS").

 

INSOMNIS, a digital media business specialising in the delivery of behavioral targeting and performance campaign solutions for its clients, will seek to leverage Phorm's proprietary technology and machine learning algorithms to identify users through a first party approach leading to more effective targeting, personalised messaging and efficient overall campaign delivery.

 

Phorm's first party data platform technology sits above digital properties, off network supply sources and real-time bidding platforms, where it synthesises user data, develops profiles and addresses users personalised with content or advertising messages at the point where the user is engaging client's websites. Brands, publishers and programmatic sources can clearly benefit when known users are able to engage with personalised content and it is therefore more effective and efficient for both the inventory and demand sides of our clients' businesses. The Company's technology provides unparalleled insight and a holistic view into digital advertising dynamics such that agencies and advertisers can achieve optimal inventory control and return on their investment.

 

 

CEO of INSOMNIS, Mr Mike Moran, commented:

 

"Brand managers have become particularly focused on whether they are messaging to their desired user base, which is often difficult to prove in the context of online advertising. Issues like privacy and viewability are becoming increasingly important to advertisers when they choose their partner for their display targeting and retargeting activity.

"We have every confidence in Phorm's tech platform and our partnership with Phorm will enable us to present our campaign metrics to clients, knowing that we have utilised first party data to deliver the brand's specific user base most efficiently. This is precisely the area where the online advertising industry needed to evolve."

 

Phorm's CEO, Timothy Smith, added:

 

"Mike Moran, Paul Grundy and their colleagues at INSOMNIS possess a wealth of ad industry expertise and relationships. Together, we've already helped a brand and publishing client in the U.K. achieve a successful campaign, which has provided validation that our initial partnership is already yielding results. We now look forward to extending this initial track record of success to the U.S. market."

 

 

-Ends-

 

 

 

For Phorm information please contact:

Phorm Corporation Limited

Timothy Smith (Chief Executive Officer) +44 (0)20 3397 6001

 

Mirabaud Securities LLP (Broker) +44 (0)20 7321 2508

Jason Woollard 

Peter Krens

 

Strand Hanson Limited (Nominated Adviser) +44 (0)20 7409 3494

James Harris Matthew Chandler James Dance

 

About Phorm

 

Phorm (PHRM:AIM) is a leading advertising-technology and first party data platform provider that enables brands and publishers to address online users with personalised content and advertising. Phorm's innovative platform delivers a more interesting online experience for the user and addressable campaign results for marketers. For more information, please visit: www.phorm.com

 

For Insomnis Media information please contact:

 

BrandMee

Marie Ellis +44 (0)7454 222611

 

About Insomnis Media

 

INSOMNIS is a digital media business specialising in behavioural targeting and driving campaign performance.

 

We use market-leading technology, which learns about our advertiser's audience, both prior to and during a campaign, which allows us to continuously improve performance by modifying CPCs/CPMs to maximise efficiency and programmatic/RTB win rates.

 

Visit us at www.insomnis-media.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALDLLLEBFXFBQ
Date   Source Headline
26th Mar 20145:00 pmRNSIntention to raise £10 million
10th Mar 20147:01 amRNSMemorandum of Understanding with China Telecom
27th Jan 20147:00 amRNSCommercial Launch in China
20th Jan 20147:00 amRNSChange of Adviser
17th Jan 20147:00 amRNSAIM Rule 17 Disclosure Schedule Two (g) Update
6th Jan 20147:00 amRNSExercise of Employee Warrants for Shares
19th Nov 20137:00 amRNSOperational Update for Phorm China
19th Nov 20137:00 amRNSEquity Placing to raise £10 million
13th Nov 20137:12 amRNSStmnt re Share Price Movement
24th Oct 201311:16 amRNSOperations Update
3rd Oct 20137:00 amRNSOperational Launch in China
30th Sep 20137:00 amRNSInterim Results
27th Sep 20137:00 amRNSOperations Update
28th Aug 201312:43 pmRNSAGM Statement
7th Aug 201310:52 amRNSStmnt re Share Price Movement
6th Aug 20137:00 amRNSAGM Statement
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
17th Jul 20139:20 amRNSIssue of Equity
28th Jun 20137:20 amRNSAnnual Report and Financial Statements
28th Jun 20137:20 amRNSTurkish Operations Update
29th May 20137:00 amRNSFinancing Update
8th May 20138:34 amRNSHolding(s) in Company
23rd Apr 201310:18 amRNSPlacing to raise £7.15 million
21st Mar 20133:20 pmRNSStatement re Share Price Movement
20th Mar 20137:00 amRNSFinancing Update
24th Jan 20137:00 amRNSChinese and Turkish Operations Update
4th Jan 20137:00 amRNSIssue of Shares
18th Dec 20127:00 amRNSIssue of Shares
17th Dec 20127:00 amRNSTurkish Operational Update
13th Dec 20127:00 amRNSTR1: Notification of major interest in shares
21st Nov 201212:33 pmRNSResult of EGM & Admission to trading
6th Nov 201211:50 amRNS£6m Placing, Contract Signature & Turkey Update
16th Oct 20127:00 amRNSCommercial Progress Update
28th Sep 20127:00 amRNSInterim Results
20th Sep 20127:00 amRNSUpdate on Turkey and Phorm China Equity Fundraise
11th Sep 20127:00 amRNSAdmission to Trading
10th Sep 20123:33 pmRNSSch 1 Update - Phorm Corporation Limited
7th Sep 20122:58 pmRNSResults of EGM - Correction
7th Sep 201212:29 pmRNSResults of EGM
5th Sep 20124:15 pmRNSNotification of Major Interests in Shares
31st Aug 20123:49 pmRNSUpdated Appendix to Schedule 1
13th Aug 20129:06 amRNSSchedule 1 - Phorm Corporation Limited
13th Aug 20127:00 amRNSPhorm Re-Domicile of Holding Company from Delaware
2nd Aug 20127:00 amRNSPlacing
9th Jul 20127:00 amRNSCommencement of Commercial Activities with TTNET
3rd Jul 201210:14 amRNSTransfer of Shares
29th Jun 20127:00 amRNSAnnual Financial Report
19th Jun 20126:01 pmRNSCorrection: AGM Result
19th Jun 201211:29 amRNSAGM Result

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.